MX2009012048A - Eliminacion de interferencia en inmunoensayos ocasionada por anticuerpos de anti-carbohidrato. - Google Patents

Eliminacion de interferencia en inmunoensayos ocasionada por anticuerpos de anti-carbohidrato.

Info

Publication number
MX2009012048A
MX2009012048A MX2009012048A MX2009012048A MX2009012048A MX 2009012048 A MX2009012048 A MX 2009012048A MX 2009012048 A MX2009012048 A MX 2009012048A MX 2009012048 A MX2009012048 A MX 2009012048A MX 2009012048 A MX2009012048 A MX 2009012048A
Authority
MX
Mexico
Prior art keywords
drug
immunoassays
elimination
interference
caused
Prior art date
Application number
MX2009012048A
Other languages
English (en)
Inventor
David Leroy Wensel
Michael Awwad
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of MX2009012048A publication Critical patent/MX2009012048A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención está dirigida a ensayos para la detección de un anticuerpo anti-fármaco en general y en particular a la detección de un anticuerpo anti-fármaco en donde el fármaco tiene una porción carbohidrato. La invención está dirigida también a ensayos para la detección de un fármaco en general y en particular a la detección de un fármaco en donde el fármaco tiene una porción carbohidrato. La invención está dirigida además a métodos para identificar sujetos apropiados para tratamiento con un fármaco que contiene una porción carbohidrato.
MX2009012048A 2007-05-07 2008-05-06 Eliminacion de interferencia en inmunoensayos ocasionada por anticuerpos de anti-carbohidrato. MX2009012048A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92814407P 2007-05-07 2007-05-07
US92843807P 2007-05-08 2007-05-08
PCT/US2008/062739 WO2008137885A1 (en) 2007-05-07 2008-05-06 Elimination of interference in immunoassays caused by anti-carbohydrate antibodies

Publications (1)

Publication Number Publication Date
MX2009012048A true MX2009012048A (es) 2010-02-24

Family

ID=39666131

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2009012048A MX2009012048A (es) 2007-05-07 2008-05-06 Eliminacion de interferencia en inmunoensayos ocasionada por anticuerpos de anti-carbohidrato.
MX2009012044A MX2009012044A (es) 2007-05-07 2008-05-06 Eliminacion de interferencia en inmunoensayos causada por anticuerpos anti-carbohidrato.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2009012044A MX2009012044A (es) 2007-05-07 2008-05-06 Eliminacion de interferencia en inmunoensayos causada por anticuerpos anti-carbohidrato.

Country Status (11)

Country Link
EP (1) EP2142925A1 (es)
JP (1) JP2010527005A (es)
KR (1) KR20100029083A (es)
CN (1) CN101680880A (es)
AU (1) AU2008247352A1 (es)
BR (1) BRPI0811290A2 (es)
CA (1) CA2686206A1 (es)
IL (1) IL201907A0 (es)
MX (2) MX2009012048A (es)
RU (1) RU2009141159A (es)
WO (1) WO2008137885A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS54249B1 (en) 2010-04-29 2016-02-29 Theradiag Sa PROCEDURE FOR DETECTION OF ANTI-MEDICINAL ANTIBODIES
MX2016010413A (es) 2014-02-11 2016-11-30 Genzyme Corp Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco.
EP3176580A1 (en) 2015-12-01 2017-06-07 Roche Diagnostics GmbH Method for reduction of interferences in immunoassays
GB201522839D0 (en) * 2015-12-23 2016-02-03 Randox Lab Ltd And Randox Teoranta Method
BR112018076569A2 (pt) * 2016-06-23 2019-04-02 Ablynx Nv ensaios farmacocinéticos melhorados para domínios variáveis simples de imunoglobulina
CN108535490A (zh) * 2017-03-06 2018-09-14 苏州和锐生物科技有限公司 生物制剂血药浓度检测方法及试剂
EP3821255A1 (en) * 2018-07-10 2021-05-19 Regeneron Pharmaceuticals, Inc. Methods for mitigating drug target interference in an anti-drug antibody (ada) immunoassay
CN113514632B (zh) * 2021-04-20 2024-06-25 中国科学技术大学 基于纳米抗体的微悬臂梁免疫传感方法
WO2023204378A1 (ko) * 2022-04-19 2023-10-26 의료법인 성광의료재단 혈액 내 항-약물항체 농도 측정을 통한 생물학적 약물에 대한 치료 반응성 예측 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705353A (en) * 1995-06-07 1998-01-06 Beckman Instruments, Inc. Method of reducing interferences in assays
US5856106A (en) * 1995-11-01 1999-01-05 Biotransplant, Inc. Determination of antibody production against administered therapeutic glycoproteins, especially monoclonal antibodies

Also Published As

Publication number Publication date
IL201907A0 (en) 2010-06-16
RU2009141159A (ru) 2011-06-20
BRPI0811290A2 (pt) 2014-10-21
KR20100029083A (ko) 2010-03-15
AU2008247352A1 (en) 2008-11-13
WO2008137885A1 (en) 2008-11-13
CN101680880A (zh) 2010-03-24
JP2010527005A (ja) 2010-08-05
MX2009012044A (es) 2009-11-18
CA2686206A1 (en) 2008-11-13
EP2142925A1 (en) 2010-01-13

Similar Documents

Publication Publication Date Title
MX2009012048A (es) Eliminacion de interferencia en inmunoensayos ocasionada por anticuerpos de anti-carbohidrato.
MY157955A (en) Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody
MX2015012823A (es) Ensayo de combinacion de antigeno-anticuerpo del virus de la hepatitis c (vhc) y metodos y composiciones para usarlo.
MX2015016389A (es) Inmumoensayo con interferencia suprimida para la deteccion de anticuerpos anti-farmacos en muestras de suero.
ZA201000093B (en) Detection of antigens carried by erythrocytes and of anti-erythrocyte antibodies
WO2005103698A3 (en) Methods and antibodies for nitrofuran detection
MY182750A (en) Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis
SG170728A1 (en) Anti-tumor cell antigen antibody therapeutics
HK1097320A1 (en) Detection of methamphetamine group drugs
WO2010065568A3 (en) METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95
MX2010013692A (es) Deteccion de uso de cannabis.
GB2449043A (en) Water soluble conjugates for electrochemical detection
RS54249B1 (en) PROCEDURE FOR DETECTION OF ANTI-MEDICINAL ANTIBODIES
WO2009055382A8 (en) One-step immunoassays exhibiting increased sensitivity and specificity
HK1126274A1 (en) T cell assays t
SG164389A1 (en) Detection of a therapeutic antibody in an experimental animal
EA200700345A1 (ru) Обогащённое антитело для выявления микобактериальной инфекции, способы применения и диагностические тесты, применяющие такое антитело
ATE481642T1 (de) Sondenkomplex
MY149500A (en) The quantitative determination of risedronate in urine by spe-lc-ms-ms
FR2968767B1 (fr) Procede et coffret pour le diagnostic in vitro du cancer de la prostate
WO2006060188A3 (en) Anti-tenascin monoclonal antibody immunoassays and diagnostic kits
WO2010053772A3 (en) Disease-associated antigens and methods of use thereof
PT1991875E (pt) Teste para a detecção de priões patológicos
ATE526582T1 (de) Generisches verfahren für latex- agglutinationstests
WO2007084570A3 (en) High sensitivity secretagogin assays and their uses for diagnosis and/or prognosis